Bio Path Holdings Inc BPTH:NASDAQ

Last Price$4.34Cboe Real-Time Last Sale as of 11:48AM ET 12/01/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.09(2.03%)
Bid (Size)$4.26 (100)
Ask (Size)$4.37 (200)
Day Low / High$4.25 - 4.45
Volume133.4 K
 

View Biotechnology IndustryPeer Comparison as of 12/01/2021

 

Bio Path Holdings Inc ( NASDAQ )

Price: $4.34
Change: -0.09 (2.03%)
Volume: 133.4 K
11:48AM ET 12/01/2021
 
 

Palisade Bio Inc ( NASDAQ )

Price: $2.11
Change: -0.22 (9.44%)
Volume: 164.5 K
12:28PM ET 12/01/2021
 
 

HTG Molecular Diagnostics Inc ( NASDAQ )

Price: $3.80
Change: -0.14 (3.55%)
Volume: 23.0 K
10:43AM ET 12/01/2021
 
 

ARCA Biopharma Inc ( NASDAQ )

Price: $2.32
Change: -0.05 (1.90%)
Volume: 378.1 K
12:38PM ET 12/01/2021
 
 

Idera Pharmaceuticals Inc ( NASDAQ )

Price: $0.66
Change: +0.009 (1.38%)
Volume: 110.7 K
12:32PM ET 12/01/2021
 

Read more news Recent News

Sector Update: Health Care Stocks Remain Lower Tuesday Afternoon
3:55PM ET 8/24/2021 MT Newswires

Health care stocks remained lower this afternoon, with the NYSE Health Care Index falling 0.2% while the SPDR Health Care Select Sector ETF (XLV) was down...

Sector Update: Health Care Stocks Falling in Tuesday Trading
1:18PM ET 8/24/2021 MT Newswires

Health care stocks were broadly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) falling 0.3% each....

Wall Street Wavers Pre-Bell, FDA's First Full Approval for COVID-19 Vaccine Buoys Sentiment
9:13AM ET 8/24/2021 MT Newswires

US stocks were struggling for a direction ahead of Tuesday's opening bell, underpinned by hopes of a faster economic recovery after the US Food and Drug...

Top Premarket Gainers
8:04AM ET 8/24/2021 MT Newswires

Triple-S Management (GTS) shares soared 45% after the company agreed to be acquired by GuideWell Mutual Holding Corporation in a deal valued at $900...

Company Profile

Business DescriptionBio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX. View company web site for more details
Address4710 Bellaire Boulevard
Bellaire, Texas 77401
Phone+1.832.742.1357
Number of Employees8
Recent SEC Filing11/12/20218-K
Chairman, President, CEO, CFO, Treasurer & CAOPeter H. Nielsen
Senior VP-Research, Development & Clinical DesignAna Tari Ashizawa
Senior VP-Finance, Accounting & AdministrationAnthony Price
Secretary & Non-Independent DirectorDouglas P. Morris

Company Highlights

Price Open$4.45
Previous Close$4.43
52 Week Range$3.30 - 24.34
Market Capitalization$31.1 M
Shares Outstanding7.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.55
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-33.63%

Analyst Ratings as of 03/10/2021

Buy
2
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset